REGULATORY AGENCY ACTION
Following Palmer's presentation,
BENHA formed a subcommittee consisting of Nancy Campbell and John Colen to
analyze all aspects of the program and
report its findings and recommendations
at the Board's next meeting.

Examination and Enforcement
Statistics. The pass rate for the January 9
state exam for nursing home administrators (NHA) was 60%; the national
exam pass rate was 54%.
In February, BENHA issued its notice
of nursing home administrators whose
licenses are suspended or revoked or who
were placed on probation through January
30; BENHA is required to publish this
information pursuant to AB 1834 (Connelly) (Chapter 816, Statutes of 1987). As
part of its implementation of AB 1834,
BENHA provides the Department of
Health Services (DHS) with a monthly list
of all changes of facility administrators
reported to the Board, as well as a list of
all nursing home administrators who have
had their licenses revoked, suspended, or
have been placed on probation during the
last three years. In return, DHS provides
BENHA with copies of enforcement actions initiated against facilities including
facility license revocation actions, final
involuntary decertifications from the
Medicare/Medi-Cal programs, and all
class "AA" and "A" citations issued after
July l, 1988. The February report reveals
that twelve NHAs are on probation, five
of whom are presently working as the
designated administrator of nursing
homes in California.
From December l, 1991 through
March 31, 1992, BENHA received three
citations from DHS for "AA" violations,
which are violations of standards which
lead to a patient's death, and 69 "A" violations, which seriously endanger a patient's
safety with a substantial probability of
death or serious bodily harm. BENHA
conducted six informal telephone counselling sessions, issued two letters of
warning, and requested three accusations
against NHAs.
BENHA Releases Newsletter. In its
February newsletter, the Board reminded
NHAs that at least ten hours, or 25%, of
each NHA's continuing education requirement must be in the area of aging or patient
care. Courses relating to patient care may
include any elements of the physical,
psychological, or sociological aspects of
care. Courses concerning aging should relate to the processes and facets of aging,
and may relate to any of its biological,
mental, or sociological implications.
LEGISLATION:
SB 2044 (Boatwright), as amended
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April 2, would declare legislative findings
regarding unlicensed activity and
authorize all Department of Consumer Affairs boards, bureaus, and commissions,
including BENHA, to establish by regulation a system for the issuance of an administrative citation to an unlicensed person who is acting in the capacity of a
licensee or registrant under the jurisdiction of that board, bureau, or commission.
[A. CPGE&ED]
SB 664 (Calderon). Existing law
prohibits nursing home administrators,
among others, from charging, billing, or
otherwise soliciting payment from any
patient, client, customer, or third-party
payor for any clinical laboratory test or
service if the test or service was not actually rendered by that person or under his/her
direct supervision, unless the patient is
apprised at the first solicitation for payment of the name, address, and charges of
the clinical laboratory performing the service. As amended March 12, this bill
would also make this prohibition applicable to any subsequent charge, bill, or
solicitation. This bill passed both the
Senate and Assembly, and is currently
awaiting Senate concurrence in Assembly
amendments.
The following bills died in committee:
AB 1191 (Epple), which would have, with
specific exceptions, required that a
physician, prior to the administration of a
physical restraint to a resident of a skilled
nursing facility or intermediate care
facility, seek consent from the resident (if
he/she has the capacity to understand and
make health care decisions) or the legal
representative of the resident; and AB 95
(Friedman), which would have
prohibited (except in an emergency) a
long-term health care facility from using
a physical restraint on a resident unless the
facility has verified that the resident has
given his/her informed consent to the use
of the physical restraint, and the informed
consent has been documented by the
physician in the resident's medical record.
AB 95 died in committee.

RECENT MEETINGS:
At its February 5 meeting, BENHA
reviewed and approved a notice which
will be sent to all licensees informing them
of BENHA's plan to raise its biennial
license renewal fee from $190 to approximately $225. At this writing, however, no legislation has been introduced to
accomplish this fee increase.
At its April 7 meeting, BENHA
reviewed its 1992 goals and objectives.
BENHA's goals include establishing a
1993-94 budget based upon available
resources that assures the continuance of

essential operations necessary to accomplish the Board's mission; obtaining
legislative authorization to increase fees
charged by the Board to ensure that adequate funds are available for the Board to
carry out its functions; seeking legislation
to move the RCFE administrator certification program from DSS to BENHA;
providing input, reviewing, and implementing the new federal nursing home
administrator standards; and taking appropriate remedial and formal disciplinary
actions against licensees who violate the
laws and regulations governing the
management and operation of long-term
care facilities.
Also at its April meeting, BENHA held
its annual election of officers and unanimously elected James Wark to serve as
chair, Nancy Campbell as vice-chair, and
Stroube Richardson as secretary.

FUTURE MEETINGS:
To be announced.

BOARD OF OPTOMETRY
Executive Officer: Karen Ollinger
(916) 323-8720

Pursuant to Business and Professions
Code section 3000 et seq., the Board of
Optometry is responsible for licensing
qualified optometrists and disciplining
malfeasant practitioners. The Board establishes and enforces regulations pertaining
to the practice of optometry, which are
codified in Division 15, Title 16 of the
California Code of Regulations (CCR).
The Board's goal is to protect the consumer patient who might be subjected to
injury resulting from unsatisfactory eye
care by inept or untrustworthy practitioners.
The Board consists of nine members.
Six are licensed optometrists and three are
public members. One optometrist position
is currently vacant due to the June 1991
resignation of Ronald Kosh. At the end of
June 1992, two more positions will become vacant upon expiration of the terms
of optometrist Gene D. Calkins and public
member Joseph D. Abella.

MAJOR PROJECTS:
Board Votes to Repeal Examination
Appeal Process. On February 20, the
Board held a public hearing regarding its
proposal to amend section 1533 and repeal
section 1533. l, Division 15, Title 16 of the
CCR, which would effectively abolish examination appeals. [ 12: 1 CRLR 89 J Currently, licensure candidates may appeal
their exam score if they fail to receive a
passing grade, cite the specific items in
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question, and adhere to specified time
limits.
According to the Board, the amendment to section 1533, which would permit
a candidate for licensure to inspect only
his/her answer sheets instead of his/her
examination papers, is based on exam
security. The Board contends that it is not
able to develop a large enough pool oftest
questions to allow for such free access to
prior examination questions without compromising the security of its examination.
The proposed amendments would also
eliminate the current two-hour time
limitation for review of one's examination
papers, as such a restriction would no
longer be appropriate.
Eyexam2000 of California, Inc., opposed the Board's proposed amendments
to section 1533, stating that without access
to the examination questions, a licensure
candidate would be effectively precluded
from making any determination as to
whether either a scoring error or a subjective scoring decision, which may otherwise be appealable, might have occurred.
Eyexam2000 noted that other professions
have similar concerns regarding examination security and have addressed them in
some manner other than completely
eliminating any opportunity for a candidate to review his/her exam and confirm
that it was appropriately scored. Additionally, Eyexam2000 contended that, without
the opportunity to review the exam itself,
candidates are forced to trust that all
exams were reviewed without human or
mechanical error and that no questions are
open to dual interpretation.
The repeal of section 1533.1 would
effectively abolish the existing process of
appealing examination results. According
to the Board's initial statement of reasons,
the appeal process requires a considerable
amount of staff time to administer-time
that could be devoted to other programsand the possibility that an applicant will
be successful on appeal does not outweigh
the burden placed on the Board; thus, the
Board contends that the appeal process
should be eliminated.
The Board's proposed elimination of
the appeal process was opposed by both
the California Optometric Association
(COA) and Eyexam2000 at the February
20 hearing. COA characterized the
elimination of the appeal provision as "inappropriate" and suggested streamlining
current procedures rather than repealing
them; COA urged the Board to retain some
type of examination appeal procedure.
Eyexam2000 also urged the Board to
reject the proposed repeal of section
1533.1, contending that the Board's own
Initial Statement of Reasons acknow-

ledges the possibility that an applicant
may be successful on appeal; thus,
Eyexam2000 argued that such a process is
worthwhile. Also, without an appeal procedure, there is no adequate method by
which either the examiners and scorers or
the applicants may monitor the reliability
of the Board's examination. Finally,
Eyexam2000 contended that there is an
inherent unfairness in requiring an applicant to undertake the burden and expense of retaking an examination when
he/she may otherwise be able to successfully appeal the results of the first exam.
Bob Miller, the Department of Consumer Affairs (DCA) legal counsel who
advises the Board, responded to these concerns by contending that actual problems
with the Board's examination are rare.
Miller informed the Board that no formal
appeal process would exist if section
1533.1 is repealed and no formal response
to candidates' questions would be required; however, applicants who do not
pass the exam could still address the
Board. After further discussion, the Board
voted 4-2 to amend section 1533 and
repeal section 1533. l. At this writing, the
Board is preparing the rulemaking file for
submission to DCA for review and approval; if approved, the rulemaking file
will be submitted to the Office of Administrative Law (OAL) for review and
approval.
Regulations Committee Meets. After
nine months of rescheduling meetings, the
Board's Legislation and Regulations
Committee finally met in Sacramento in a
January 10 closed session to review a
number of the Board's regulations; Board
members Joseph Dobbs and Mel Santos,
Executive Officer Karen Ollinger, and
legal counsel Bob Miller were present.
The Committee reviewed sections 1502,
1510, 1518, 1526, 1535, and 1536,
Division 15, Title 16 of the CCR, and
discussed potential regulations relating to
the accreditation of optometry schools by
the Board, mobile practice, and optometric technicians/assistants. At the
Board's February 20 meeting, the
Committee's recommendations were discussed and the Board voted to commence
the rulemaking process to pursue the following three proposals:
-First, section 1502 currently
delegates certain responsibilities to the
Board's secretary or, in the secretary's absence, to the Executive Officer. These
duties include receiving and filing accusations; issuing notices of hearing and statements of issues; receiving and filing
notices of defense; determining the time
and place of disciplinary hearings under
Government Code section 11508; issuing
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subpoenas; and setting dates for hearings.
The Board voted to seek an amendment to
section 1502 to instead delegate these
responsibilities solely to the Executive
Officer.
-Second, section 1510 describes conduct which constitutes "professional inefficiency" by an optometrist. The Board
will pursue an amendment to section 1510
to add the failure to inform any patient for
whom treatment is prescribed, in terms
understandable to that patient (or legal
guardian, if appropriate), of the risks and
benefits of the treatment as constituting
professional inefficiency.
-Third, the Board will seek amendments to section 1535, which describes
examination requirements. The Board's
proposed amendments would require the
successful completion of the National
Board Examination in Optometry, in addition to the successful completion of the
Board examination described in section
1531, Title 16 of the CCR. This change
would allow an applicant for licensure to
take these exams in any sequence.
At this writing, these proposed actions
have not been published in the California
Regulatory Notice Register.
The Board agreed not to amend section
1518, regarding the criteria necessary for
the issuance of a fictitious name permit;
section 1526, requiring proof of CPR certification for license renewal; and section
1536, which describes the Board's continuing education requirements. Also, the
Board determined that there is no need to
change or expand its current practice of
accepting the accreditation of optometry
schools from the Council on Optometric
Education. The Board will hold factgathering hearings on mobile practice and
optometric technician/assistant issues
prior to determining whether regulatory
action is necessary. These informal hearings are scheduled for September 15 and
22; the locations have yet to be determined.
Optometry Refresher Course Seeks
Instructors. Under section 1530.l of the
Board's regulations, all graduates of
foreign schools must furnish satisfactory
evidence of their completion of a curriculum which is "reasonably equivalent"
to that required by California law. If the
foreign curriculum is deficient, the applicant is permitted to remedy deficiencies
and qualify for admission to the Board's
examination upon furnishing satisfactory
evidence of adequate remedial education.
While this section establishes the possibility of remedial education, no such
remedial education program has ever been
available to foreign graduates, such that
their only option is to retake and complete
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an entire course of study at a Board-approved optometry school. During the summer of 1990, after years of debate, controversy, and intervention by Senate President pro Tempore David Roberti, the
Board was required by the legislature to
spend $300,000 of its reserve fund to establish an approved refresher course for all
optometrists, especially graduates of
foreign and out-of-state optometric
schools. {10:4 CRLR 113; 10:2/3 CRLR
87-88]
The course was designed by the Board
and the University of California, and commenced in September 1991 in Los Angeles through the UCLA Health Sciences
Extension Program. It includes classes in
anatomy, neuro-anatomy, histology,
physiology, biochemistry, microbiology,
and pathology; the cost of the program to
students is $3,000.
However, the program is experiencing
difficulty in acquiring instructors to teach
clinical optometries. The administrator of
the refresher course, Dr. Feelie Lee of
UCLA, has approached both the Southern
California College of Optometry (SCCO)
and the University of California School of
Optometry at Berkeley, but has been unable to obtain a commitment from instructors to teach. Lee is exploring other options such as hiring instructors from out of
state, although this probably will not be a
viable option due to budget constraints.
The Board itself has not taken an active
role to ensure the success of the program;
although it spent over $300,000 to implement the eighteen-month course, the
Board now contends that it lacks jurisdiction to actively support the course. At its
February 20 meeting, the Board discussed
its alleged lack of jurisdiction to assist
UCLA. The Board attributed the difficulties of finding instructors to the degree of
specialization required and reluctance on
the part of the two optometry schools in
California to have their faculty participate.
According to Board members, SCCOwhich, because of its close proximity to
UCLA, is the most feasible choice for
obtaining instructors-is hesitant to have
its faculty teach the refresher course because it fears competition from the UCLA
program and does not want the use of its
faculty to be construed as an endorsement
of the program. The Board determined
that it has no control over the process of
selecting instructors and that there is little
it can do to facilitate the process. Board
member Pamela Miller stated that, legally
and ethically, assisting UCLA is out of the
Board's jurisdiction.
Karen McGagin, Special Assistant to
DCA Director Jim Conran, denounced the
Board's position, stating that DCA
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believes that the Board, having expended
over $300,000 on the course, must take an
active role to ensure the course is a success
instead of sitting back and watching it fail.
DCA contends that the Board must exhaust all opportunities to assist UCLA and
explore avenues other than the two optometry schools in California. McGagin
noted that without assistance from the
Board, the course could fail; she said that
DCA is willing to help the Board resolve
existing problems.
The Board responded to DCA's concerns by placing ads in its newsletter and
having Board members meet with SCCO
representatives to further the process of
finding instructors. The notice placed in
the Board's newsletter garnered some
response from California optometrists.
However, at its May meeting, the Board
again insisted that it is not a sponsor of the
program.
Board Commences Occupational
Analysis. The Board recently awarded a
contract to Human Resources Strategies to
undertake an occupational analysis of
practicing optometrists to test their level
of knowledge and to determine the scope
of their practice. By examining the profession, the Board hopes to determine
whether its current licensure examination
tests appropriate areas of knowledge. The
analysis was scheduled to begin in June
and is expected to take one year to complete; a mid-year report is tentatively
scheduled to be presented at the Board's
November meeting.
Board Responds to DCA Request for
Informatwn. The Department of Consumer Affairs recently required the Board
to provide DCA with current information
regarding the Board's role and functions.
For example, DCA asked the Board to
discuss the need for regulation in the field
of optometry. The Board responded by
stating that it receives over 400 complaints per year against optometrists practicing in the state; many of these complaints allege serious violations of the law
and often indicate a substantial risk to the
public. According to the Board, "the basis
for regulating optometrists is the tremendous harm which can be caused to the
consumer of optometric services. In the
past year, the board has taken formal disciplinary action against ten licensed optometrist [sic] for violations of the law .... "
According to the Board's 1991 newsletter,
only one of these disciplinary actions
resulted in actual time off practice (see
infra "Board Publishes Newsletter").
The Board explained that a doctor of
optometry is a primary health care
provider who can diagnose, manage, and
treat conditions (and, in many states, dis-

eases) of the human eye and visual system.
An incompetent practitioner can inflict
serious damage to the structures of the eye
which could cause problems ranging from
mild discomfort to blindness; in addition,
an incompetent optometrist could delay
treatment of very serious disease conditions such as brain tumors, glaucoma,
diabetic retinopathy, and hypertensive
retinopathy.
According to the Board, its regulation
of optometry "does not restrict the supply
of practitioners. The State Board Examination is available to all who have
graduated from an accredited college or
school of optometry. All candidates who
pass the National Board Examination and
the California State Board Examination
are allowed to practice in the state of
California. The supply of practitioners is
limited only by the number of candidates
that pass (or do not pass) the state board
examination."
Although acknowledging that the
"closest root profession to optometry is
ophthalmology," the Board stated that
"the ophthalmologist receives little or no
training in the areas that are specifically
unique to optometry." Further, the Board
opined that optometry cannot be compared to any other vision care profession
and that, if the Board's functions were
taken over by some other entity, "consumers of optometric services and the optometrists themselves would not receive
the same level of service they now
receive .... "
Board Publishes Newsletter. In April,
the Board released its newsletter entitled
News and Annual Report 1991. This
newsletter, which is directed at practicing
optometrists and others interested in optometry, includes a list of the Board's
members, committees, and staff; provides
information on the 1992 licensure examination; describes the optometry
refresher course; discusses changes in the
mandatory continuing education (CE)
program and the CE audit; and provides
updates on the Board's enforcement activities, regulations, and legislation. The
newsletter also includes the names of nine
persons against whom the Board took disciplinary action between January I 99 I
and February 1992; six of these cases were
stipulations which resulted in no time off
practice, and only one case resulted in
revocation.
LEGISLATION:
SB 2044 (Boatwright), as amended
April 2, would declare legislative findings
regarding unlicensed activity and
authorize all DCA boards, bureaus, and
commissions, including the Board of Op-
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tometry, to establish by regulation a system for the issuance of an administrative
citation to an unlicensed person who is
acting in the capacity of a licensee or
registrant under the jurisdiction of that
board, bureau, or commission. [A.
CPGE&EDJ
AB 2566 (O'Connell). Existing law
limits the amount the Board of Optometry
may charge for its license application and
renewal fees. Currently, the Board's application fee may not exceed $75; if an
applicant is found ineligible to take the
exam, the applicant is entitled to a refund
of no more than $50. The current renewal
fee is limited to $85. As introduced
February IO, this Board-sponsored bill
would raise the application fee ceiling to
$275; the refund ceiling to $175; and the
renewal ceiling to $150. [S. B&PJ
AB 3242 (Isenberg). Under existing
law, the practice of optometry includes,
among other things, the examination of
the human eye or its appendages; the
analysis of the human vision system,
either subjectively or objectively; and the
determination of the powers or range of
human vision and refractive states of the
human eye, including the scope of its
general condition. As amended April 21,
this bill would provide that the practice of
optometry includes examination of the adnexa of the human eye and the analysis
and diagnosis of conditions of the human
vision system, either subjectively or objectively. [A. Health]
SB 664 (Calderon). Existing law
prohibits optometrists, among others,
from charging, billing, or otherwise
soliciting payment from any patient,
client, customer, or third-party payor for
any clinical laboratory test or service if the
test or service was not actually rendered
by that person or under his/her direct supervision, unless the patient is apprised at
the first solicitation for payment of the
name, address, and charges of the clinical
laboratory performing the service. As
amended March 12, this bill would also
make this prohibition applicable to any
subsequent charge, bill, or solicitation.
This bill would also make it unlawful for
any optometrist to assess additional charges for any clinical laboratory service that
is not actually rendered by the optometrist
to the patient and itemized in the charge,
bill, or other solicitation of payment. This
bill passed both the Senate and the Assembly and is currently awaiting Senate
concurrence in Assembly amendments.
AB 1479 (Burton). The Robert W.
Crown California Children's Services Act
requires the Department of Health Services (DHS) to establish and administer a
program of services for physically defec-

tive or handicapped persons under the age
of 21 years; the Act requires the DHS
Director to establish those conditions
coming within the definition of "handicapped child." As amended May 29, this
bill would require any condition established by the Director which is treatable
by an ophthalmologist to be deemed
treatable by an optometrist if the condition
is within the scope of practice of optometry. [S. H&HSJ
SB 613 (Calderon). Existing law requires a registered optometrist who temporarily practices optometry outside or
away from his/her regular place of practice to deliver to each patient there fitted
or supplied with glasses a specified
receipt. As amended July 10, this bill
would instead require a registered optometrist to furnish to each patient there
fitted or supplied with prescription spectacle lenses a specified receipt. [A.
Health]
The following bills died in committee:
AB J/24 (Friuelle), which would have
established the right, duty, responsibility,
and obligation of a person engaged in the
practice of optometry to exercise professional judgment in the performance of
his/her duties, including but not limited to
scheduling, diagnosis, treatment within
the scope of practice of optometry, and
referral of patients; and AB 1358 (Floyd),
which would have specified that a
registered optometrist who performs any
act constituting the practice of optometry
while employed by another optometrist, a
physician, or any entity authorized by the
laws of this state to employ an optometrist
to perform acts constituting the practice of
optometry is bound by and subject to the
optometry statutes and regulations.
LITIGATION:
In an unpublished February 4 decision,
the Second District Court of Appeal ruled
that section 1526, Title 16 of the CCR, a
1988 regulation which requires optometrists to obtain certification to administer cardiopulmonary resuscitation
(CPR) as a condition of licensure or
license renewal, is invalid as it exceeds the
scope of authority granted to the Board.
In Halverson v. State Board of Optometry, No. B055937, the plaintiff filed
a complaint pursuant to Government Code
section 11350, seeking a declaration that
the CPR requirement is invalid and an
injunction enjoining its enforcement.
Under section 11350, a regulation may be
declared invalid if the agency's determination that the regulation is reasonably
necessary to effectuate the purpose of the
statute is not supported by substantial
evidence. At the time it adopted the rule,
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the Board argued it was necessary because, by 2000, half of those people seeking optometric services will be age 45 or
older and at risk of having a sudden cardiac arrest. Because the legislature mandated the Board to protect the "health and
safety of those members of the public
availing themselves of services offered
and performed in optometric offices," the
Board contended that its CPR regulation
is necessary to provide that protection.
The trial court upheld the rule.
The Second District reversed and
rejected the Board's justification, finding
that the Board is authorized to establish
minimum qualifications and levels of
competency to practice optometry; according to the court, nothing in the practice of optometry has any relationship to
the need to administer CPR. The court
found no evidence that any procedure in
the practice of optometry increases the
risk of cardiac arrest or that one is more
likely to suffer cardiac arrest at an optometric office than at any other place. The
court noted that while CPR certification
for all optometrists may be desirable, it
should not be a prerequisite for an optometry license.
Following the Second District's ruling,
the Board began informing optometrists,
through its newsletter and license renewal
notices, that CPR is no longer a requirement for licensure.
RECENT MEETINGS:
At its February 20 meeting, the Board
unanimously voted to delegate the review
of requests for extensions to complete
continuing education (CE) requirements
to the Executive Officer and/or the President of the Board.
Also in February, the Board noted that
it is randomly auditing optometrists to ensure compliance with CE requirements;
the random audits began in August 1991.
With each license renewal notification, the
Board instructs the optometrist to return
documentation of completion of required
CE hours. If the documentation is verified,
a renewal is issued; if it cannot be verified,
the file is turned over to the Board's enforcement division. As of February 19, 270
of 300 optometrists audited have submitted appropriate documentation of required hours of CE.
At its May 13 meeting, the Board brief!y discussed the possibility of accepting
the National Board Examination in Optometry as California's licensing examination. Some Board members believe
that California should adopt that exam
because other states are changing to it and
it would be less expensive to administer;
other members expressed concern about
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losing control over the examination. The
Board plans to address this issue at a future
meeting.

FUTURE MEETINGS:
August 21-22 in Sacramento.
November 20-21 in Los Angeles.

BOARD OF PHARMACY
Executive Officer: Patricia Harris
(916) 445-5014
Pursuant to Business and Professions
Code section 4000 et seq., the Board of
Pharmacy grants licenses and permits to
pharmacists, pharmacies, drug manufacturers, wholesalers and sellers of hypodermic needles. It regulates all sales of
dangerous drugs, controlled substances
and poisons. The Board is authorized to
adopt regulations, which are codified in
Division 17, Title 16 of the California
Code of Regulations (CCR). To enforce its
regulations, the Board employs full-time
inspectors who investigate accusations
and complaints received by the Board.
Investigations may be conducted openly
or covertly as the situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized by
law to suspend or revoke licenses or permits for a variety of reasons, including
professional misconduct and any acts substantially related to the practice of pharmacy.
The Board consists of ten members,
three of whom are public. The remaining
members are pharmacists, five of whom
must be active practitioners. All are appointed for four-year terms.

MAJOR PROJECTS:
Attorney General Issues Opinion
Regarding Out-of-State Pharmacies. On
March 3, the Attorney General's Office
filed Opinion No. 91-305, responding to
the following three questions submitted
by Assemblymember Tricia Hunter: (])
whether California laws governing pharmacies apply to out-of-state mail order
pharmacies which fill prescriptions and
mail them to people in California; (2)
whether California's current regulation of
out-of-state mail order pharmacies is consistent with the commerce clause of the
U.S. Constitution; and (3) under California law, whether a generic type drug listed
on the negative drug formulary established by the Director of Health Services
may be substituted for a brand name drug
by an out-of-state pharmacy when filling
prescriptions and mailing them to people
in California. { 11:3 CRLR 101)
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The opinion answered all three questions affirmatively, under specified conditions. Regarding the first question, the
Attorney General noted that Business and
Professions Code section 4084.6 prohibits
an out-of-state pharmacy from doing business in California unless it obtains an outof-state distributor's license from the
Board of Pharmacy, or is registered with
the Board as a nonresident pharmacy. Outof-state drug distributors are required by
law to comply with Chapter 9 of the Business and Professions Code, which contains most of the statutes that govern pharmacies in California, and Division 21 of
the Health and Safety Code. Nonresident
pharmacies must comply with Business
and Professions Code sections 4050.1 and
4383, and Health and Safety Code section
11164. Thus, the opinion concluded that
California laws do apply in limited circumstances to out-of-state pharmacies
which fill prescriptions and mail them to
people in California; the extent of their
applicability depends on how the particular pharmacy is licensed.
Regarding California's regulation of
out-of-state pharmacies, the Attorney
General noted that in determining whether
a state-created impact on interstate commerce falls within permissible bounds, the
U.S. Supreme Court established a
"balancing test" in Pike v. Bruce Church
lnc., 397 U.S. 137, 142 (1970). Under that
test, where the statute regulates evenhandedly to effectuate a legitimate local
public interest, and its effects on interstate
commerce are only incidental, it will be
upheld unless the burden imposed on such
commerce is clearly excessive in relation
to the putative local benefits. According to
the opinion, a local purpose which has
traditionally been favored by the Court is
one promoting the health and safety of a
state's inhabitants. Based on its findings
that the state will be given considerable
latitude given the subject matter of the
regulation, the laws are applied indiscriminately to in- and out-of-state pharmacies, and the burden on interstate commerce is "clearly minimal in relation to the
legitimate state purpose of protecting the
health and welfare of California residents," the Attorney General's Office concluded that California's regulation of outof-state pharmacies does not offend the
Commerce Clause.
Regarding the third question, the Attorney General noted that, with certain
exceptions and qualifications, Business
and Professions Code section 4047.6 allows a pharmacist to substitute a generic
drug for a brand name drug when filling a
prescription. Business and Professions
Code section 4047.7 provides that one

such exception applies when the generic
drug type or drug product has been listed
on the "negative drug formulary" by the
Director of the Department of Health Services (OHS); if a drug is listed by the OHS
Director on the negative drug formulary, a
pharmacist may not substitute it for a
brand name drug. The Attorney General
found that compliance with section
4047.7 is required of all pharmacies in
California and any pharmacy licensed as
an out-of-state drug distributor pursuant to
Business and Professions Code section
4084.6. However, because pharmacies
registered as nonresident pharmacies need
comply only with Business and Professions Code sections 4050.1 and 4383 and
Health and Safety Code section 11164 in
order to maintain their registration and do
business in California, pharmacies
registered as nonresident pharmacies may
substitute a generic type drug listed on the
negative drug formulary established by
the OHS Director for a brand name drug
when filling prescriptions and mailing
them to people in California. According to
the opinion, however, no drug is currently
listed on the negative drug formulary.
FDA Clarifies Policy Regarding New
Drug Repacking. Last July, the Board
sought clarification of the U.S. Food and
Drug Administration's (FDA) Compliance Policy Guide (CPG) 7132c.06,
which states that "each step in the
manufacture and processing of a new drug
or antibiotic, from handling of raw ingredients to final packaging, must be approved by FDA, whether carried out by
the original manufacturer or by some subsequent handler or repacker of the
product. Pharmacists are not exempt from
these statutory requirements; however, the
agency regards mixing, packaging, and
other manipulations of approved drug
[sic] by licensed pharmacists, consistent
with the approved labeling of the product,
as an approved use of the product if conducted within the practice of pharmacy,
i.e., filling prescriptions for identified
patients." The Board asked FDA to clarify
whether "the breaking down of bulk drugs
for prescription or known need" constitutes manufacturing. Specifically, the
Board asked whether manipulation by a
pharmacist of an FDA-approved drug
constitutes manufacturing (which requires
registration as a manufacturer) when"(])
it is contrary to the manufacturer's package insert, or (2) it is prepared for a
specific patient in advance, but in anticipation of, a prescription, or (3) it is
prepared in anticipation of receiving one
or more prescriptions for the product, as
manipulated, but for a specific patient."
{12:1 CRLR 91; 11:4 CRLR 104)
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